Pretoria: Experts from leading South African research and clinical institutions have moved to assure the public that it remains safe to use sanitary pads. Health Minister Dr. Aaron Motsoaledi led a joint media briefing to address public concerns about the safety of sanitary pads following a study by the Department of Chemistry at the University of Free State. The study, published in the Science of the Total Environment Journal, highlighted the presence of endocrine disrupting chemicals (EDCs) in sanitary pads.
According to South African Government News Agency, the study found low levels of EDCs in sanitary pads, a finding consistent with their presence in many everyday products. Dr. Motsoaledi emphasized that while these chemicals were detected, no causal relationship has been established between them and adverse health outcomes in women or girls. Regulatory authorities in South Africa are committed to ensuring the continued safety of these products.
The study examined 16 sanitary pads and seven pantyliners, all purchased online, revealing small quantities of EDCs in the products, including those marketed as chemical-free. These findings initiated discussions among the National Department of Health and experts from various institutions, including the South African Medical Research Council (SAMRC), the South African Society of Obstetricians and Gynaecologists (SASOG), and the World Health Organization (WHO).
SAMRC President Prof. Ntobeko Ntusi outlined the ubiquity of EDCs and noted that their detection does not equate to evidence of harm. He reassured that the exposure levels found in the study were low and emphasized the need for perspective in interpreting these findings.
Obstetricians and gynaecologists from SASOG and SASREG also highlighted that the potential for EDCs to interfere with hormones does not translate to an actual risk, given the low concentrations found in the study. They stressed that no causation between EDC exposure from sanitary pads and health issues like infertility or cancer has been established.
SAHPRA CEO Dr. Boitumelo Semete stated that sanitary products are classified as low-risk medical devices, and manufacturers must comply with global standards. SAHPRA has not received any reports of adverse events related to these products and will continue to monitor them.
WHO representatives noted that while EDC exposure is a global issue, there is no clear evidence linking it to health risks from menstrual products. They emphasized the importance of balancing chemical presence with public health benefits when making regulatory decisions.
The University of Free State clarified that their research does not claim a direct link between short-term use of menstrual products and specific health conditions. The findings are intended to spur further scientific inquiry rather than advise on product usage.
Regulatory bodies like the South African Bureau of Standards and the National Consumer Council ensure that sanitary products meet safety standards. The UFS study's findings do not necessitate additional regulatory actions, according to Motsoaledi.
The media briefing, part of the Social Protection, Community and Human Development Cluster, included representatives from various ministries and local and international experts, reinforcing the commitment to public safety.